Aveanna Healthcare (NASDAQ: AVAH) issues 2025 and 2026 guidance update

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. filed a current report describing new financial outlook information. On January 14, 2026, the company issued a press release updating its full year guidance for fiscal 2025 and announcing its full year guidance for fiscal 2026. The guidance details are contained in a press release furnished as Exhibit 99.1 and a January 2026 investor presentation furnished as Exhibit 99.2. These materials are provided for informational purposes under Items 2.02 and 7.01 and are treated as “furnished,” not “filed,” under securities laws.

Insights

Equity research analyst

Aveanna furnished updated 2025 and new 2026 guidance via press release and deck.

Aveanna Healthcare Holdings Inc. has provided investors with updated financial guidance for fiscal 2025 and initial guidance for fiscal 2026. The actual figures are contained in a press release and investor presentation referenced as Exhibits 99.1 and 99.2.

The information is designated as “furnished” rather than “filed,” which limits its exposure to certain securities law liabilities while still making the outlook available to the market. The company also highlights its investor relations website as a distribution channel for time-critical information.

The overall directional change of guidance is not described in this excerpt, so the effect on the investment thesis depends on the specific numbers and assumptions provided in the attached materials and future company disclosures.

0001832332false00018323322026-01-142026-01-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 14, 2026

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
400 Interstate North Parkway SE
Atlanta, Georgia				30339
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 770 441-1580

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AVAH		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On January 14, 2026, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our"), issued a press release updating its full year guidance for fiscal year 2025 (year ending January 3, 2026) and announcing its full year guidance for fiscal year 2026 (year ending January 2, 2027). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 2.02.

Item 7.01 Regulation FD Disclosure.

On January 14, 2026, the Company made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.2 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.

Use of our Website and Social Media to Distribute Material Company Information

We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.

The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, and this Item 7.01, including in Exhibit 99.2 attached hereto, are “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
99.2		Aveanna Investor Presentation - January 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			AVEANNA HEALTHCARE HOLDINGS INC.
Date:	January 14, 2026	By:	/s/ Matthew Buckhalter
			Matthew Buckhalter Chief Financial Officer (Principal Financial Officer)

FAQ

What did Aveanna Healthcare (AVAH) disclose in this 8-K filing?

Aveanna Healthcare Holdings Inc. disclosed that it updated its full year guidance for fiscal 2025 and issued initial full year guidance for fiscal 2026, with details in a press release and investor presentation.

Where can investors find Aveanna (AVAH) 2025 and 2026 guidance details?

The specific guidance figures are contained in a press release furnished as Exhibit 99.1 and an investor presentation furnished as Exhibit 99.2, which is also available in the Investors section of www.aveanna.com.

Are Aveanna Healthcare’s updated guidance materials considered filed with the SEC?

No. The information in Items 2.02 and 7.01 of this report, including Exhibits 99.1 and 99.2, is expressly described as “furnished” and not “filed” for purposes of Section 18 of the Exchange Act.

How does Aveanna (AVAH) distribute important company information to investors?

Aveanna states it uses its website, particularly the Investors section of www.aveanna.com, to post press releases, investor presentations, and financial information as a channel for important and time-critical company information.

What exhibits are attached to this Aveanna Healthcare 8-K?

The 8-K includes Exhibit 99.1 (press release announcing updated full year 2025 and initial full year 2026 guidance), Exhibit 99.2 (Aveanna investor presentation – January 2026), and Exhibit 104 (cover page interactive data file).

Who signed this Aveanna Healthcare (AVAH) 8-K report?

The report was signed on behalf of Aveanna Healthcare Holdings Inc. by Matthew Buckhalter, Chief Financial Officer and principal financial officer.